ERC PROOF OF CONCEPT GRANTS

Expected Outcome: The topic encompasses actions within the scope of the co-programmed European Partnership on Globally Competitive Space Systems (‘Space Partnership’) in the areas of satellite communication (SatCom), Earth Observation (EO) and New Commercial Space Transportation Solutions and is part of cohesive activities in the domain of digital developments under the grand heading of “digitalisation for commercial space solutions”. Digitalisation is a major enabler for enhancing the value of an End-to-End EO and SatCom system. Under the area of Using Space on Earth related to SatCom and EO, below this topic focusses on the Mid to High TRL level developments of key technologies [1] required to strengthen competitiveness in these domains, contributing to the preparation of EO and SatCom demonstration missions. Projects are expected to contribute to one or several of the following outcomes: Favouring a competitive and sustainable European Space Sector; Enable the European Space Industry to maintain a significant share of the global connectivity market; Advanced Earth observation and SatCom payloads, technologies and processing means (on ground and in space); Advanced EO and SatCom…

Expected Outcome: The targeted outcomes reflect the above challenges and cover a comprehensive Front End module design which: Covers the FR3 range as defined by the relevant Agenda Item of WRC 27 (7 to 15 GHz range) with possible extension up to 24 GHz if required by some regional implementations, with inherent tuning capabilities to accommodate potential regional variations. Mitigates interferences with incumbent FR3 band users and maximises sharing capabilities across the band in line with the European regulatory approach on spectrum sharing. Enables integration of a large number of antenna elements beyond the State of the Art and support massive MIMO implementation with compensation of increased path loss compared to 5G FR1 implementations. Enables at least an order-of-magnitude increase in RF processing compared to 5G FR1 implementations. Enables 5G cell site reuse and minimises deployment complexity on top of 5G sites deployment. Enables low-cost and low energy implementation of the elementary constituent modules, efficient packaging and is mainly based on the integration of microelectronics heterogeneous technologies where European industry has strong expertise and…

Expected Outcome: Project results are expected to contribute to all of the following expected outcomes: Reinforcing EU strategic autonomy by reducing non-EU dependencies on critical space EEE components and related technologies across their entire supply chain; Providing unrestricted access to critical space EEE components and related technologies relevant for EU space missions (Galileo, EGNOS, Copernicus, IRIS 2 and EU pilot missions on In-Orbit Space Operations and Quantum Gravimetry); Developing or regaining capacity to operate independently in space by developing resilient space EEE components and related technologies supply chains, relying on EU supply chains and/or trustable and reliable supply chains not affected by non-EU export restrictions; Enhancing competitiveness by developing products and capabilities reaching equivalent or superior performance level than those from outside the EU and compete at worldwide level. Scope: Unrestricted access to state-of-art space EEE components and related technologies is a pre-requisite for the EU space industry responding to EU space missions. However, especially for some families of components, the available solutions in EU do not…

Expected Outcome: this topic is a continuation for the co-funded European partnership for research in nuclear materials (CONNECT-NM) and constitutes the EU’s contribution to the 2026-2027 budgetary period. This action aims to provide additional funding to the co-funded European partnership on nuclear materials that brings together European entities that have a national mandate for research in materials science and deal with nuclear materials. It aims to pool their resources in order to achieve critical mass and improve safety, as well as efficiency and effectiveness, when implementing materials solutions in the nuclear domain across Europe. The scope of the partnership on nuclear materials covers the research interests of all Member States and Associated Countries dealing with nuclear materials research. It is not limited to countries that generate nuclear power. The grant to the partnership will contribute to the expected outcomes specified in topic HORIZON-EURATOM-2023-NRT-01-04. The consortium that won the grant under topic HORIZON-EURATOM-2023-NRT-01-04 is uniquely placed to submit a proposal to continue the envisioned partnership. The consortium for the present topic may…

Scope: Proposals innovations should address one or more of the several domains : WBG substrates to reduce EU dependency on material and provide more sustainable, industrially compatible solutions. WBG platform for cost effectiveness, available in 300mm for GaN and/or SiC to improve yield and power density and close gaps in the value chain. A toolbox (e.g. wafer cut, smart stacking, thin layer transfer, epitaxy, UWBG materials) for further innovation schemes. Next generation or optimised new power semiconductor devices fitting their application. Adding intelligence to power semiconductor devices on control and/or sensor side. Facilitate the propagation of EU Packaging/Integration excellence along the entire value chain e.g. pre-packages or power semiconductor device packaging solutions to enable power device/system integration and strengthen Europe’s competitiveness in advanced packaging. Explore the use of heterogeneous and functional integration for improved performance, reliability, robustness and cost competitiveness. Rising operative voltage, frequency, current and thermal features that are common challenge on power electronics across the different application sectors. Provide…

Expected Outcome: Objectives and profile of the ERC Plus Grant Principal Investigator The ERC Plus Grant supports outstanding Principal Investigators who address a major scientific challenge. Applications for ERC Plus Grants should be for projects that could not be carried out with a regular ERC grant. Applicants should explain how the proposed project aims go beyond those of a regular ERC project, for example, because they have a vision to transform their field or open a new field of research. Scholars at all career stages can apply for an ERC Plus Grant if they have an outstanding record of scientific achievement at the forefront of their field. Their intellectual leadership will be evaluated in comparison to peers at their own career stage. It is expected that a researcher may be the Principal Investigator of only one ERC Plus Grant in their lifetime. Applicants should be aware that every year, only some 30 ERC Plus Grants can be awarded across all fields and all career stages, compared to approximately 1000 Starting, Consolidator and Advanced Grants. This level of competitiveness should be taken into account when considering whether to submit an application. Size of ERC Plus…

Expected Outcome: Objectives and profile of the ERC Advanced Grant Principal Investigator The objective of the Advanced Grant is to support excellent Principal Investigators that are established research leaders. An ERC Advanced Grant Principal Investigator is expected to be an active researcher with a track record of significant research achievements. Size of ERC Advanced Grants Advanced Grants may be awarded up to a maximum of EUR 2 500 000 for a period of 5 years . The maximum amount of the grants is reduced pro rata temporis for projects of a shorter duration. Additional funding up to EUR 1 000 000 * can be requested to cover further eligible costs (e.g. start-up costs, major equipment, access to large facilities, major experimental and field work costs) when these are necessary to carry out the proposed work. The requests for additional funding must be duly justified in the proposal. Additional funding is not subject to pro rata temporis reduction for projects of shorter duration. * Except for Principal Investigators in Starting, Consolidator, or Advanced Grant re-locating to the EU or an Associated Country from elsewhere to take up their ERC grant. In this case, the maximum…

The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will broadly focus on closing the treatment gap for individuals with alcohol use disorder (AUD); within this focus, there are five major areas of emphasis: (1) increasing access to treatment for AUD, (2) making treatment for AUD more appealing, (3) examining cost structures and insurance systems, (4) conducting studies on dissemination and implementation of existing evidence-based approaches to treating AUD, and (5) reducing health disparities as a means of addressing the treatment gap in AUD for health disparity populations.

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications for projects to expand, improve, or transform the utility of mammalian cancer and tumor models for translational research. With this NOFO, the NCI intends to encourage submission of projects devoted to demonstrating that mammalian models or their derivatives used for translational research are robust representations of human biology, are appropriate to test questions of clinical importance, and provide reliable information for patients' benefit. These practical goals contrast with the goals of many mechanistic, NCI-supported R01 projects that employ mammals, or develop and use mammalian cancer models, transplantation tumor models, or models derived from mammalian or human tissues or cells for hypothesis-testing, non-clinical research. Among many other possible endeavors, applicants in response to this FOA could propose demonstrations of how to overcome translational deficiencies of mammalian oncology models, define new uses of mammalian models or their genetics for unexplored translational challenges, advance standard practices for use of translational models, test approaches to validate and credential models, or challenge current practices for how models are used translationally

The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Required mechanism focusing on alcohol treatment and recovery research. This NOFO will focus broadly on topics relevant for treatment of and recovery from alcohol use disorder (AUD), including: medications development, precision medicine, behavioral therapies and mechanisms of behavioral change (MOBC), recovery, translational research, and innovative methods and technologies for AUD treatment and recovery.